Back to search

Article

Adjuvanting Coxevac® with QuilA® skews Coxiella burnetii-induced inflammatory responses towards a sustained Th1-CD8+-mediated activation and increases protection in an experimental goat model

2022-08-19

Abstract excerpt

<title>Abstract</title> <p>Coxevac® is the EMA-approved veterinary vaccine for the protection of cattle and goats against Q Fever, a zoonotic bacterial disease due to Coxiella burnetii. Since Coxevac® reduces bacterial shedding and clinical symptoms but does not prevent infection, novel, ready-to-use vaccine formulations are needed to increase its immunogenicity. Here, a goat vaccination-challenge model was used...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2df70a4-1169-50bb-bd79-991b29be94b7
DOI
10.21203/rs.3.rs-1897579/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adjuvanting Coxevac® with QuilA® skews Coxiella burnetii-induced inflammatory responses towards a sustained Th1-CD8+-mediated activation and increases protection in an experimental goat modelDOI 10.21203/rs.3.rs-1897579/v1
Select a neighboring publication to make it the new centre.